Atezolizumab plus Chemotherapy in Small-Cell Lung Cancer. Reply

Affiliations

Comment

Leora Horn et al. N Engl J Med. 2019.

. 2019 Feb 28;380(9):889-890.

doi: 10.1056/NEJMc1900123.

No abstract available

Comment on

First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.
Horn L, Mansfield AS, Szczęsna A, Havel L, Krzakowski M, Hochmair MJ, Huemer F, Losonczy G, Johnson ML, Nishio M, Reck M, Mok T, Lam S, Shames DS, Liu J, Ding B, Lopez-Chavez A, Kabbinavar F, Lin W, Sandler A, Liu SV; IMpower133 Study Group. Horn L, et al. N Engl J Med. 2018 Dec 6;379(23):2220-2229. doi: 10.1056/NEJMoa1809064. Epub 2018 Sep 25. N Engl J Med. 2018. PMID: 30280641 Clinical Trial.
Atezolizumab plus Chemotherapy in Small-Cell Lung Cancer.
Weiss GJ, Addeo A. Weiss GJ, et al. N Engl J Med. 2019 Feb 28;380(9):888-889. doi: 10.1056/NEJMc1900123. N Engl J Med. 2019. PMID: 30811920 No abstract available.
Atezolizumab plus Chemotherapy in Small-Cell Lung Cancer.
Diker O. Diker O. N Engl J Med. 2019 Feb 28;380(9):889. doi: 10.1056/NEJMc1900123. N Engl J Med. 2019. PMID: 30811921 No abstract available.